Sakar Healthcare's Robust Growth Spurred by Oncology Success

Sakar Healthcare Ltd reported a significant 91% rise in net profit for January-March 2025-26, achieving Rs 11.02 crore. The company's fiscal year showed a 74% net profit increase, emphasizing its oncology division's role in growth, completing 60 contracts with oncology products.

Sakar Healthcare Ltd, headquartered in Ahmedabad, announced a remarkable 91% surge in net profit for the January-March quarter of 2025-26, reaching Rs 11.02 crore compared to Rs 5.76 crore in the previous year. Revenue from operations during this period saw a 42% rise, amounting to Rs 71.09 crore, reflecting the company's ongoing expansion efforts.

For the fiscal year ending March 31, 2026, Sakar Healthcare reported a net profit increase of 74%, totaling Rs 30.48 crore, up from Rs 17.50 crore in the previous year. Overall revenue climbed 42% to Rs 251.73 crore from Rs 177.58 crore, driven by strategic advancements in key sectors.

Managing Director Sanjay Shah highlighted the pivotal role of the oncology division in shaping future growth, having successfully completed over 60 contracts in the oncology segment. The continuous focus on this area underscores its importance in the company's expansion strategy.